Conflicts of interest: Bias or boon?

Tomaszewski, Christian

doi:10.1007/bf03161170

Cited by 5 publications

(2 citation statements)

References 23 publications

(15 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Discovery after the fact may risk embarrassment and legal action 5 . Full disclosure by providers of real or potential conflicts of interest should be given to employers, colleagues, patients, and when presenting and publishing work 6,7 …”

Section: Disclosurementioning

confidence: 99%

A warning to physicians: Changing landscape of the corporate‐provider relationship

Shah

Smith

Ziv

et al. 2008

Otolaryngol.--head neck surg.

View full text Add to dashboard Cite

In 2007, the United States federal government recovered $1.54 billion for fraud in the health care industry. The government's unwavering and continuing commitment to enforcement and criminal actions compel the need for a stronger provider understanding of the regulatory framework within which corporate-provider relations must be structured. This commentary aims to review briefly the need for such education in order to protect providers from legal action and offers a straightforward, proactive compliance approach to optimize patient care and technological innovation while maintaining appropriate remuneration.

show abstract

Section: Disclosurementioning

confidence: 99%

A warning to physicians: Changing landscape of the corporate‐provider relationship

Shah

Smith

Ziv

et al. 2008

Otolaryngol.--head neck surg.

View full text Add to dashboard Cite

show abstract

“…Llama la atención que particularmente en el mundo quirúrgico los conflictos de interés sostenidos en aspectos principalmente económicos han adquirido el "status" de un problema mayor actual en el cuidado médico, la educación continua y la investigación, al no definir correctamente aquello que está bien desde el punto de vista ético de lo que no corresponde hacer. Al no publicitar la existencia de estos conflictos, se expone el profesional a sanciones de todo tipo 44 , al quedar descubierto el bienestar de los pacientes o la validez científica de los ensayos clínicos por ser imprecisos, confusos o discutibles al obtener potenciales ganancias económicas que no eran el objetivo de esas prácticas. Todas estas consideraciones hay que valorarlas para impedir y contribuir en forma fehaciente con el mejor conocimiento de la realidad.…”

Section: Posibles Solucionesunclassified